Solid state forms of macrocyclic kinase inhibitors
ZA201000400B
Methods and compositions for the treatment of cancer, tumors, and tumor related disorders
EP2224932A1
Cancer treatment using cox-2 inhibitor and antimetabolite combinations
CA2707424A1
Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
CA2700665A1
Combination therapy for the treatment of cancer using cox-2 inhibitors and dual inhibitors of egfr [erbb1] and her-2 [erbb2]
WO2009042612A1
Therapies for treating cancer using combinations of cox-2 inhibitors and aromatase inhibitors or combinations of cox-2 inhibitors and estrogen receptor antagonists
WO2009042618A1
Therapies for treating cancer using combinations of cox-2 inhibitors and anti-her2(erbb2) antibodies or combinations of cox-2 inhibitors and her2(erbb2) receptor tyrosine kinase inhibitors
EP2170062A1
Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
WO2009009776A2
Patient selection and therapeutic methods using markers of prostaglandin metabolism
